Clinical Performance of Flowable Giomer Versus Nanofilled Composite in Conservative Occlusal Cavities

September 24, 2025 updated by: Amina Ahmed Abdellatif Hassan Gaafar, Cairo University

Performance of Flowable Giomer Versus Nanofilled Flowable Composite With or Without Giomer Coat In Conservative Occlusal Cavities: 18 Months Randomized Clinical Trial

With limited evidence-based information in literature the goal of this clinical trial is to learn about Flowable Giomer and compare it to Nanofilled Flowable Composite in Conservative Occlusal Cavities. It is beneficial to evaluate the newly introduced material using a randomized controlled clinical trial to test the null hypothesis that this new flowable giomer (Shofu™ Beautifil Injectable X, Shofu Dental Corp., Japan) and conventional resin-based nano-filled composite (Filtek™ Z350 XT 3M ESPE, USA) which will then be coated with (Shofu™ PRG Barrier Coat, Shofu Dental Corp., Japan) will have the same clinical performance as flowable resin composite as a preventative restorative restoration in permanent molars.

Study Overview

Detailed Description

This study will be conducted to clinically evaluate caries prevention and marginal integrity of flowable giomer and flowable resin composite coated with S-PRG in comparison to flowable resin composite as a preventative resin restoration in patients requiring minimally invasive simple class I cavities in permanent molars over 18 months test period.

Teeth that meet the inclusion criteria will be selected. The occlusal surfaces will be cleaned by pumice and a low speed polishing brush. Baseline recording of carious lesions will be carried out using DIAGNOdent pen. Cavity preparation will be carried out using number 330 (Mani, Inc., Japan) bur.

All the tested materials Shofu™ Beautifil Injectable X, (Shofu Dental Corp., Japan flowable composite) and Filtek™ Z350 XT (3M ESPE, USA) Flowable composite: Conventional resin-based nano-filled flowable composite which will then be coated with Shofu™ PRG Barrier Coat, (Shofu Dental Corp., Japan) will be used according to manufacturer instructions and comparator restorative material Filtek™ Z350 XT (3M ESPE, USA) Flowable composite.

All restorations will be finished using flame-shaped finishing stone (Mani, Inc., Japan) and polished using rubber cups (Kerr Corporation, Orange, CA, USA).

The primary and secondary outcomes will be measured at four intervals 1 week after placement, 6 months follow up, 12 months follow up and 18 months follow up.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt
        • Faculty of Dentistry, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Unilateral or Bilateral small Class I carious lesions
  • Patients with good oral health
  • Small Class I carious lesion in occlusal pits and fissures

Exclusion Criteria:

  • Existing systemic diseases
  • Severe medical complications
  • Allergy history concerning methacrylates
  • Pregnancy
  • Heavy smoking
  • Evidence of severe bruxism, clenching or temporomandibular joint disorders
  • Presence of existing occlusal restoration
  • Periapical or pulpal pathology
  • Tooth hypersensitivity
  • Possible prosthodontic restoration of teeth
  • Endodontically treated teeth
  • Severe periodontal affection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Flowable Giomer
Patients with conservative carious class I occlusal cavities will be treated with Shofu™ Beautifil Injectable X, Shofu Dental Corp., Japan flowable composite Novel bio-active flowable resin containing nano S-PRG (Surface Pre-Reacted Glass ionomer).
Pre-reacted Glass Ionomer (PRG) filler is added to resin to create giomer, a dental adhesive material. Fluoride release and recharge, acid resistance, an anti-plaque effect, dentin remineralization, and acid buffering capacity are some of the benefits of giomer.
Experimental: Nano-filled Flowable Composite with S-PRG barrier coat
Patients with conservative carious class I occlusal cavities will be treated with Filtek™ Z350 XT 3M ESPE, USA Flowable composite: Conventional resin-based nano-filled flowable composite which will then be coated with Shofu™ PRG Barrier Coat, Shofu Dental Corp., Japan.

Flowable composites are claimed to have a higher wetting ability of the tooth surface and thus ensure penetration into all surface irregularities in layers of minimal thickness. As a result of the higher amount of filler particles, it is noted that flowable composites have less porosity than conventional resin-based sealants. Moreover, flowable composite materials have better mechanical properties which lead to increased durability and longevity of the restoration.

The PRG Barrier Coat is a resinous coating substance that shields the enamel surface from demineralization brought on by acidic attack. Near the coated surface, S PRG filler ions in PRG Barrier Coat have been found to have an acid-neutralizing effect. F and Sr released by PRG Barrier Coat can be effectively absorbed by the tooth substrate to prevent demineralization thus hindering the progression of caries.

Active Comparator: Nano-Filled Flowable Composite
Patients with conservative carious class I occlusal cavities will be treated with Filtek™ Z350 XT 3M ESPE, USA Flowable composite: Conventional resin-based nano-filled flowable composite.
Flowable composites are claimed to have a higher wetting ability of the tooth surface and thus ensure penetration into all surface irregularities in layers of minimal thickness. As a result of the higher amount of filler particles, it is noted that flowable composites have less porosity than conventional resin-based sealants. Moreover, flowable composite materials have better mechanical properties which lead to increased durability and longevity of the restoration.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fracture and Retention of Material
Time Frame: T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up

World Dental Federation (FDI) criteria (Hickel et al.,2010) Scores:

  1. Clinically excellent/ very good 1.1 No fractures/cracks
  2. Clinically good 2.1 Small hairline crack
  3. Clinically sufficient/ satisfactory 3.1 Two or more larger hairline cracks and/or material chip not affecting the marginal integrity or approximal contact
  4. Clinically unsatisfactory (but repairable) 4.1 Material chip fractures which damage marginal quality or approximal contacts 4.2 Bulk fractures with partial loss (less than half of the restoration)
  5. Clinically poor (replacement necessary) 5.1 Partial or complete loss of restoration or multiple fractures
T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occlusion and wear
Time Frame: T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
World Dental Federation (FDI) criteria
T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
Marginal Adaptation
Time Frame: T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
World Dental Federation (FDI) criteria
T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
Form and contour
Time Frame: T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
World Dental Federation (FDI) criteria
T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
Dental hard tissue defects at restoration margins
Time Frame: T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
World Dental Federation (FDI) criteria
T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
Postoperative hypersensitivity/pulp status
Time Frame: T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
World Dental Federation (FDI) criteria
T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up
Incidence of new carious lesions
Time Frame: T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up

Intra-oral quantitative light-induced fluorescence applied on the occlusal surface of permanent molars with initial Class I caries using DIAGNOdent pen

Scores:

0 - 14 indicate a healthy occlusal surface 15 - 20 indicate the presence of enamel caries, 21 or more indicate the presence of dentinal caries

T0= 1 week postoperative T1= 6 months follow up T2= 12 months follow up T3= 18 months follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2023

Primary Completion (Actual)

June 19, 2025

Study Completion (Actual)

June 21, 2025

Study Registration Dates

First Submitted

October 18, 2023

First Submitted That Met QC Criteria

October 20, 2023

First Posted (Actual)

October 24, 2023

Study Record Updates

Last Update Posted (Estimated)

September 29, 2025

Last Update Submitted That Met QC Criteria

September 24, 2025

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Giomer Based Class I Cavities

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Occlusal Caries

Clinical Trials on Flowable Giomer

Subscribe